Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

143 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reproductive organ involvement in women undergoing radical cystectomy for urothelial bladder cancer: a nationwide multicenter study.
Kato M, Taoka R, Miki J, Saito R, Fukuokaya W, Matsui Y, Yamamoto S, Matsue T, Hatakeyama S, Kawahara T, Matsuda A, Kawai T, Sazuka T, Sano T, Urabe F, Kashima S, Naito H, Murakami Y, Miyake M, Daizumoto K, Matsushita Y, Hayashi T, Inokuchi J, Sugino Y, Shiga K, Yamaguchi N, Yamamoto S, Yasue K, Abe T, Nakanishi S, Hashine K, Fujii M, Nishihara K, Matsumoto H, Tatarano S, Wada K, Sekito S, Maruyama R, Nishiyama N, Nishiyama H, Kitamura H, Uchida J; Japan Urological Oncology Group. Kato M, et al. Among authors: sazuka t. Int J Clin Oncol. 2024 Oct 9. doi: 10.1007/s10147-024-02636-7. Online ahead of print. Int J Clin Oncol. 2024. PMID: 39379757
Development and validation of a model to predict the outcomes of radical cystectomy in patients with bladder cancer.
Fukuokaya W, Miki J, Taoka R, Saito R, Matsui Y, Hatakeyama S, Kawahara T, Matsuda A, Kawai T, Kato M, Sazuka T, Sano T, Urabe F, Kashima S, Naito H, Murakami Y, Nishiyama N, Nishiyama H, Kitamura H, Kimura T. Fukuokaya W, et al. Among authors: sazuka t. Int J Urol. 2024 Sep 18. doi: 10.1111/iju.15585. Online ahead of print. Int J Urol. 2024. PMID: 39291802
TNFSF9 Is Associated with Favorable Tumor Immune Microenvironment in Patients with Renal Cell Carcinoma Who Are Treated with the Combination Therapy of Nivolumab and Ipilimumab.
Isoda B, Kandori S, Sazuka T, Kojima T, Nitta S, Shiga M, Nagumo Y, Fujimoto A, Arai T, Sato H, Mathis BJ, Wu CL, Jan YH, Ichikawa T, Nishiyama H. Isoda B, et al. Among authors: sazuka t. Int J Mol Sci. 2024 Jul 6;25(13):7444. doi: 10.3390/ijms25137444. Int J Mol Sci. 2024. PMID: 39000552 Free PMC article.
Association Between Residual Urine Volume and Recurrence Among Patients at High Risk of Non-Muscle-Invasive Bladder Carcinoma With Versus Without Bacillus Calmette-Guérin Treatment.
Murakami Y, Sazuka T, Tsukamoto R, Sato H, Ando K, Kanesaka M, Yamada Y, Imamura Y, Sakamoto S, Ichikawa T. Murakami Y, et al. Among authors: sazuka t. Cureus. 2024 May 30;16(5):e61345. doi: 10.7759/cureus.61345. eCollection 2024 May. Cureus. 2024. PMID: 38947615 Free PMC article.
Implications of unconventional histological subtypes on magnetic resonance imaging and oncological outcomes in patients who have undergone radical prostatectomy.
Kurokawa K, Yamada Y, Sakamoto S, Horikoshi T, Sato K, Nanba S, Kubota Y, Kanesaka M, Fujimoto A, Takeuchi N, Shibata H, Sazuka T, Imamura Y, Tsuzuki T, Uno T, Ichikawa T. Kurokawa K, et al. Among authors: sazuka t. Sci Rep. 2024 Jun 27;14(1):14868. doi: 10.1038/s41598-024-65681-2. Sci Rep. 2024. PMID: 38937563 Free PMC article.
Oncological outcomes of prophylactic urethrectomy at the time of radical cystectomy for bladder cancer: A nationwide multi-institutional study.
Miki J, Fukuokaya W, Taoka R, Saito R, Matsui Y, Hatakeyama S, Kawahara T, Matsuda A, Kawai T, Kato M, Sazuka T, Sano T, Urabe F, Kashima S, Naito H, Murakami Y, Nishiyama N, Nishiyama H, Kitamura H, Kimura T; Japan Urological Oncology Group. Miki J, et al. Among authors: sazuka t. Int J Urol. 2024 Sep;31(9):1009-1016. doi: 10.1111/iju.15505. Epub 2024 May 31. Int J Urol. 2024. PMID: 38822533
The LAT1 inhibitor JPH203 suppresses the growth of castration-resistant prostate cancer through a CD24-mediated mechanism.
Saito S, Ando K, Sakamoto S, Xu M, Yamada Y, Rii J, Kanaoka S, Wei J, Zhao X, Pae S, Kanesaka M, Goto Y, Sazuka T, Imamura Y, Reien Y, Hamaguchi-Suzuki N, Saito S, Hirayama Y, Hashimoto H, Kanai Y, Ichikawa T, Anzai N. Saito S, et al. Among authors: sazuka t. Cancer Sci. 2024 Jul;115(7):2461-2472. doi: 10.1111/cas.16191. Epub 2024 Apr 24. Cancer Sci. 2024. PMID: 38655663 Free PMC article.
143 results